Concepedia

Jesús Gómez-Navarro

JG

49

Publications

4.9K

Citations

31

H-Index

1996

Active since

Affiliations

Pfizer (United States)(Current)

University of Alabama at Birmingham

University of California, Los Angeles

The University of Texas MD Anderson Cancer Center

UCLA Jonsson Comprehensive Cancer Center

Jesús Gómez-Navarro is an author at Pfizer (United States) specializing in medicine, immunology, and radiation oncology.

Top concepts

Publications per year

1996–2019

49

Publications

49

Phase III Randomized Clinical Trial Comparing Tremelimumab With Standard-of-Care Chemotherapy in Patients With Advanced Melanoma

Antoni Ribas, Richard Kefford, Margaret Marshall et al. · Journal of Clinical Oncology · 2013 · 811 citations · Full text

Antitumor Activity in Melanoma and Anti-Self Responses in a Phase I Trial With the Anti-Cytotoxic T Lymphocyte–Associated Antigen 4 Monoclonal Antibody CP-675,206

Antoni Ribas, Luis H. Camacho, Gabriel Lopez‐Berestein et al. · Journal of Clinical Oncology · 2005 · 584 citations

Phase I/II Trial of Tremelimumab in Patients With Metastatic Melanoma

Luis H. Camacho, Scott Antonia, Jeffrey A. Sosman et al. · Journal of Clinical Oncology · 2009 · 314 citations

Phase II Study of the Anti-Cytotoxic T-Lymphocyte–Associated Antigen 4 Monoclonal Antibody, Tremelimumab, in Patients With Refractory Metastatic Colorectal Cancer

Ki Y. Chung, Ira Gore, Lawrence Fong et al. · Journal of Clinical Oncology · 2010 · 303 citations · Full text

Phase II Trial of Tremelimumab (CP-675,206) in Patients with Advanced Refractory or Relapsed Melanoma

John M. Kirkwood, Paul Lorigan, Peter Hersey et al. · Clinical Cancer Research · 2010 · 238 citations · Full text

Rows per page

1–5 of 49